RecruitingNot ApplicableNCT05830305

MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors


Sponsor

The University of Hong Kong

Enrollment

140 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled trial investigates the efficacy and safety of mobile health intervention in managing hypertension after Intracerebral Hemorrhage (ICH).


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether a mobile health app called WeRISE — which helps survivors of intracerebral hemorrhage (bleeding into the brain) monitor and manage their blood pressure at home — can improve outcomes and reduce the risk of another stroke or brain bleed. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with intracerebral hemorrhage (bleeding into the brain, not from trauma) - At hospital discharge, your level of disability (Modified Rankin Scale) is 4 or less (meaning you have some ability to function independently or with minimal assistance) - You or your caregiver have access to and can use the WeRISE app and can monitor blood pressure at home **You may NOT be eligible if...** - Your life expectancy is less than 1 year - You are unable to use the app or participate in follow-up - You cannot safely lower your blood pressure (e.g., you have severe artery narrowing in the brain, a history of fainting from low blood pressure, or other contraindications) - You have a severe bleeding disorder or very low platelet count - You have severe kidney or liver disease - You are allergic to multiple classes of blood pressure medication Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMobile health intervention

A protocol-based intervention via phone calls, which includes anti-hypertensive drug adjustment and reinforcement of lifestyle modification, will be implemented.


Locations(1)

Queen Mary Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05830305


Related Trials